Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2010-07-19
2011-12-06
Kim, Jennifer M (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
08071599
ABSTRACT:
The invention relates to the use of eszopiclone for the treatment of low-level, chronic pain and fatigue associated with pain.
REFERENCES:
patent: 5786357 (1998-07-01), Young et al.
patent: 6319926 (2001-11-01), Cotrel et al.
patent: 6436936 (2002-08-01), Young et al.
patent: 6444673 (2002-09-01), Cotrel et al.
patent: 6864257 (2005-03-01), Cotrel et al.
patent: 7125874 (2006-10-01), Cotrel et al.
patent: 7381724 (2008-06-01), Cotrel et al.
patent: 7465729 (2008-12-01), Wessel et al.
patent: 7776858 (2010-08-01), Wessel et al.
patent: 2005/0164987 (2005-07-01), Barberich
patent: 2005/0176680 (2005-08-01), Lalji et al.
patent: 2005/0215521 (2005-09-01), Lalji et al.
patent: 2005/0267176 (2005-12-01), Barberich
patent: 2007/0299055 (2007-12-01), Lalji et al.
patent: 2008/0175903 (2008-07-01), Hopkins et al.
patent: 2010/0004251 (2010-01-01), Barberich
patent: WO9310787 (1993-06-01), None
patent: WO 2005060968 (2005-07-01), None
patent: WO 2005063248 (2005-07-01), None
patent: WO 2005063297 (2005-07-01), None
patent: WO 2005079851 (2005-09-01), None
patent: WO 2005097132 (2005-10-01), None
patent: WO 2008070000 (2008-06-01), None
International Search Report and Written Opinion from corresponding International Application No. PCT/US2005/011593, mailed Dec. 23, 2005.
Affleck G, Urrows S, Tennen H, Higgins P, Abeles M, Seqeuntial daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia pain 68:363-368 (1996).
Asnis GM, Chakrabarty A, DuBoff EA, et al; Zolpidem for persistent insomnia in SSRI-treated depressed patients J Clin Psychiastry 60:668-676 (1999).
Barone P, Amboni M., Vitale C, Bonavita V., Treatment of nocturnal disturbance and excessive daytime sleepiness in Parkinson's disease, Neurology 63:S35-S38 (2004).
Benca RM, Ancoli-Israel A, Moldofsky H., Special considerations in insomnia diagnosis and management: Depressed, elderly, and chronic pain populations J Clin Psychiatry 65 (Suppl 8):26-35 (2004).
Billiard M, Bentley A. Is insomnia best categorized as a symptom or a disease? Sleep Medicine 5(Suppl 1):S35-S40 (2004).
Bliwise DL, Sleep disorders in Alzheimer's disease and other dementias, Clin. Cornerstone 6 Suppl 1A:S16-28 (2004).
Bloom BJ, Owens JA, McGuinn M, Nobile C., Shaeffer L, Alario AJ, Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis; J Rheumatol 29:169-173 (2002).
Bourguignon C, Labyak SE, Taibi D, Investigating sleep disturbances in adults with rheumatoid arthritis, Holist Nurs Pract 17:241-249 (2003).
Breslau N, Roth T, Rosenthal L, Andreski P, Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults, Biol Psychiatry 39:411 418 (1996).
Chang PP, Ford DE, Mead LA et al., Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study, Am J Epidemiol. 146:105-114 (1997).
Dorsey CM, Lee KA, Scharf MB Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: A 4-week, randomized, multicenter, double-blind placebo-controlled study Clin Ther 16:873-897 (2004).
Drewes AM Pain and sleep disturbances with special reference to fibromyalgia and rheumatoid arthritis, Rheumatology (Oxford) 38:1035-1038 (1999).
Drewes AM, Nielsen KD, Hansen B, Taagholt SJ, Bjerregard K, Svendsen L, A longitudinal study of clinical symptoms and sleep parameters in rheumatoid arthritis, Rheumatology (Oxford) 39:1287-1289 (2000).
Drewes AM, Svendsen L, Taagholt, Bjerregard k, Nielsen KD, Hansen B, Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions, Br J Rheumatol 37:71-81 (1998).
Ford DE, Kamerow DB, Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?, JAMA 262:1479-1484 (1989).
Ford DE, Cooper-Patrick L, Sleep disturbances and mood disorders:an epidemiologic perspective, Depress Anxiety 14:3-6 (2001).
Gillin JC, Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand Suppl. 393:39-43 (1998).
Hyyppa MT, Kronholm E, Quality of sleep and chronic illnesses J Clin Epidemiol 42:633-638 (1989).
Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 158:1099-1107 (1998).
Koren D, Arnon I, Lavie P, et al. Sleep complaints as early predictors of posttraumatic stress disorder: a 1-year prospective study of injured survivors of motor vehicle accidents. Am J Psychiatry 159:855-857 (2002).
Livingston G, Blizard B, Mann A, Does sleep disturbance predict depression in elderly people? A study in inner London, Br J Gen Pract. 43:445-448 (1993).
Londborg PD, Smith WT, Glaudin V, Painter Jr. Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression., J. Affect Disord. 61:73-79 (2000).
Mahowald MW, Mahowald ML, Bundlie SR, Ytterberg SR, Sleep fragmentation in rheumatoid arthritis Arthritis Rheum 32:974-983 (1989).
McCall MV, A psychiatric perspective on insomnia, J Clin Psychiatry 62(Suppl 10):27 32 (2001).
McCurry SM, Ancoli-Israel S, Sleep dysfunction in Alzheimer's disease and other dementias Curr Treat Options Neurol 5:261-272 (2003).
Nierenberg AA, Keefe BR, Leslie VC et al, Residual symptoms in depressed patients who respond acutely to fluoxetine J Clin Psychiatry 60:221-225 (1999).
Nolen, WA, Hypnotics as concurrent medication in depression Jrnl of Affective Disorders 28 (1993) 179-188.
O'Bryant SE, Palav A, McCaffrey RJ, A review of symptoms commonly associated with menopause: implications for clinical neuropsychologists and other health care providers, Neuropsychol Rev. 13:145-152 (2003).
Perlis ML, Giles DE, Buysse DJ, et al. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 42:209-212 (1997).
Punjabi NM, Shahar E, Redline S, et al, Investigators SHHS, Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study Am J Epidemiol 160:521-530 (2004).
Renko A, Hiltunen L, Laakso M, et al. The relationship of glucose tolerance to sleep disorders and daytime sleepiness Diabetes Res Clin Pract 67:84-91 (2005).
Rickels K, Schweizer E, Case WG, DeMartinis N, Greenblatt DJ, Mandos LA, Espana FG. Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability, J, Clin Psychopharmacol 18:145-153 (1998).
Riemann D, Voderholzer U, Primary Insomnia: a risk factor to develop depression, J Affect Disord 76:255-259 (2003).
Shaver JL, Women and sleep, Nurse Clin North Am. 37:707-718 (2002).
Smith WT, Londborg PD, Glaudin V, Painter Jr. Shortterm augmentation of fluoxetine with clonazepam in the treatment of depression: a doub-blind study, Am J. Psychiatry 155:1339-1345 (1998).
Smith WT, Londborg PD, Glaudin V, Painter Jr. Summit Research Network. Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?, J Affect Disord 70:251-259 (2002).
Thorpy MJ, Sleep disorders in Parkinson's disease Clin Cornerstone 6 Suppl 1A:S7-15 (2004).
Tishler M, Barak Y, Paran D, Yaron M., Sleep disturbances, fibromyalgia and primary Sjogren's syndrome Clin Exp Rheumatol 15:71-74 (1997).
Van Cauter E, Polonsky KS, Scheen AJ, Roles of circadian rhythmicity and sleep in human glucose regulation Endocr Rev 18:716-738 (1997).
Walsh JK, Clinical and socioeconomic correlates of insomnia; J Clin Psychiatry 65 (Suppl 8):13-19 (2004).
Zamir G, Press J, Tal A, Tarasiuk A, Sleep fragmentation in children with juvenile rheumatoid arthritis J Rheumatol 25:1191-1197 (1998).
Furukawa et al., “Antidepressant and benzodiazepine for major depression,” The Cochrane Collaboration®, pp. 1-43; (2005).
Furukawa et al., “Antidepressant and benzodiazepine for major depression,” John Wiley & Sons, Ltd., (1), 1-43, (2005).
Cohen, et al.; “Sleep in chronic pain: problems and treatments,” Intl Review of Psychiatry; vol. 12, No. 2: pp. 115-126 (2000).
Drewes, et al.; “Zopiclone as Night Medication in Rheumatoid Arthritis,” Scand J Rheumatol;
Caron Judy
Wessel Thomas
Heslin Rothenberg Farley & & Mesiti P.C.
Kim Jennifer M
Sunovion Pharmaceuticals Inc.
LandOfFree
Methods of treatment of chronic pain using eszopiclone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treatment of chronic pain using eszopiclone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment of chronic pain using eszopiclone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4264231